PRP4K is a HER2-regulated modifier of taxane sensitivity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PRP4K is a HER2-regulated modifier of taxane sensitivity

Published:2015-04-01 Issue:7 Volume:14 Page:1059-1069
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Corkery Dale P¹,Le Page Cécile²,Meunier Liliane²,Provencher Diane²³,Mes-Masson Anne-Marie²⁴,Dellaire Graham¹⁵⁶

Affiliation:

1. Department of Biochemistry & Molecular Biology; Dalhousie University; Halifax, NS Canada

2. Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM) and Institut du cancer de Montréal; Montréal, QC Canada

3. Division de gynéco-oncologie; Université de Montréal; Montréal, QC Canada

4. Département de médecine, Université de Montréal; Montreal, QC Canada

5. Department of Pathology; Dalhousie University; Halifax, NS Canada

6. Beatrice Hunter Cancer Research Institute; Halifax, NS Canada

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384101.2015.1007775

Reference46 articles.

1. Taxanes, microtubules and chemoresistant breast cancer

2. Resistance to Chemotherapy in Ovarian Carcinoma

3. Taxanes in combined modality therapy for solid tumors

4. Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance

5. Microtubule Targeting Agents: Basic Mechanisms of Multidrug Resistance (MDR)

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the Impact of Aberrant Splicing Machinery on Drug Resistance in Breast Cancer: Identifying Targets for Innovative Counteractive Strategies;Overcoming Breast Cancer Therapy Resistance;2024

2. Advances in the Application of Radionuclide-Labeled HER2 Affibody for the Diagnosis and Treatment of Ovarian Cancer;Frontiers in Oncology;2022-06-15

3. Tinker, Tailor, Tumour Suppressor: The Many Functions of PRP4K;Frontiers in Genetics;2022-02-24

4. Microtubule-Interfering Drugs: Current and Future Roles in Epithelial Ovarian Cancer Treatment;Cancers;2021-12-12

5. Haploinsufficient tumor suppressor PRP4K is negatively regulated during epithelial‐to‐mesenchymal transition;The FASEB Journal;2021-10-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3